GITNUXREPORT 2026

Brain Aneurysm Statistics

Brain aneurysms affect millions and can rupture with severe consequences, but risk varies and treatment advances offer hope.

Rajesh Patel

Rajesh Patel

Team Lead & Senior Researcher with over 15 years of experience in market research and data analytics.

First published: Feb 13, 2026

Our Commitment to Accuracy

Rigorous fact-checking · Reputable sources · Regular updatesLearn more

Key Statistics

Statistic 1

Sudden severe headache in 97% of ruptured cases

Statistic 2

Nausea and vomiting occur in 70-80% of rupture patients

Statistic 3

Neck stiffness in 66% of subarachnoid hemorrhage cases

Statistic 4

CT scan detects 95% of acute subarachnoid hemorrhages

Statistic 5

MRI/MRA used for screening in high-risk patients

Statistic 6

Digital subtraction angiography gold standard for aneurysm detection

Statistic 7

Visual disturbances in 20% of ruptured cases

Statistic 8

Loss of consciousness in 67% at rupture

Statistic 9

Seizures occur in 10-25% post-rupture

Statistic 10

Lumbar puncture confirms blood in CSF if CT negative

Statistic 11

CTA has 92-97% sensitivity for aneurysms >3mm

Statistic 12

Functional outcomes assessed by mRS scale

Statistic 13

Photophobia in 30% of warning leaks

Statistic 14

Sentinel headaches precede rupture in 40-50%

Statistic 15

Focal deficits depend on location, e.g., III nerve palsy

Statistic 16

Hunt-Hess scale predicts outcomes

Statistic 17

Fisher scale for CT blood predicts vasospasm

Statistic 18

Transcranial Doppler monitors vasospasm

Statistic 19

Cranial nerve palsies in unruptured giant aneurysms

Statistic 20

Mass effect symptoms in large aneurysms

Statistic 21

WFNS scale for coma assessment

Statistic 22

DSA detects 95% of aneurysms >2mm

Statistic 23

Perimesencephalic SAH non-aneurysmal 10%

Statistic 24

About 6.5 million people in the US have an unruptured brain aneurysm

Statistic 25

Brain aneurysms affect approximately 3-5% of the general population

Statistic 26

Incidence of subarachnoid hemorrhage from aneurysm rupture is 6-10 per 100,000 person-years

Statistic 27

Women are 1.6 times more likely to have brain aneurysms than men

Statistic 28

Peak incidence of aneurysm rupture occurs between ages 40-60

Statistic 29

African Americans have higher rupture rates

Statistic 30

Annual incidence of aneurysmal SAH is 10 per 100,000

Statistic 31

Prevalence higher in Finland at 85 per 100,000 for SAH

Statistic 32

Lifetime risk of rupture for unruptured aneurysm 0.5-2%

Statistic 33

Aneurysms found incidentally in 3.6% of autopsies

Statistic 34

Hispanic population has lower prevalence than Caucasians

Statistic 35

Age-adjusted incidence decreasing due to hypertension control

Statistic 36

Global SAH incidence 7.9 per 100,000 person-years

Statistic 37

Japanese population has higher incidence 22.7/100,000

Statistic 38

Unruptured aneurysms detected in 1-2% of routine imaging

Statistic 39

Multiple aneurysms in 20-30% of patients

Statistic 40

Children <18 have aneurysms in 1-2% of pediatric strokes

Statistic 41

Migraine sufferers have 1.5-2x higher prevalence

Statistic 42

Incidence in elderly >65 rising with imaging

Statistic 43

Saccular aneurysms 90% of cases

Statistic 44

Mycotic aneurysms 1-2% from infection

Statistic 45

Trauma-related pseudoaneurysms 5%

Statistic 46

AVM-associated aneurysms 10-15%

Statistic 47

Coiling preferred endovascular treatment in 70% of cases

Statistic 48

Clipping surgery used in complex aneurysms

Statistic 49

Nimodipine reduces poor outcomes by 30% in SAH

Statistic 50

Endovascular repair has 5-10% lower complication rate than open surgery

Statistic 51

Flow diversion stents used for large wide-neck aneurysms

Statistic 52

Antifibrinolytics not recommended routinely

Statistic 53

Surgical clipping recurrence rate 3-5%

Statistic 54

Pipeline embolization device for fusiform aneurysms

Statistic 55

Vasospasm treated with intra-arterial verapamil

Statistic 56

Hydrocephalus in 20-30% of SAH cases requiring EVD

Statistic 57

Stent-assisted coiling for wide-neck aneurysms

Statistic 58

Barbiturate coma for refractory ICP

Statistic 59

Decompressive craniectomy in 10-15% severe cases

Statistic 60

Statins may reduce vasospasm incidence

Statistic 61

Clazosentan failed phase III for vasospasm

Statistic 62

Triple-H therapy for vasospasm (outdated)

Statistic 63

Milrinone for refractory vasospasm

Statistic 64

EVD infection rate 5-10%

Statistic 65

Hypothermia trials failed for neuroprotection

Statistic 66

Endovascular success 90-95% in selected cases

Statistic 67

40-50% mortality rate for ruptured aneurysms

Statistic 68

66% of rupture survivors have permanent neurological deficits

Statistic 69

Unruptured aneurysms rupture risk 1% per year average

Statistic 70

Size >7mm increases rupture risk to 4% per year

Statistic 71

Posterior circulation aneurysms rupture risk 2x higher

Statistic 72

Rebleeding risk highest in first 24 hours at 4-6%

Statistic 73

30-day mortality for ruptured aneurysms 35-45%

Statistic 74

Good outcome (mRS 0-2) in 40% of survivors

Statistic 75

ISAT trial showed coiling better for anterior circulation

Statistic 76

BRAT trial equivalence in long-term outcomes

Statistic 77

Cognitive impairment in 50-75% of SAH survivors

Statistic 78

1-year mortality post-rupture 25% for good grade

Statistic 79

Depression in 30-50% SAH survivors at 1 year

Statistic 80

Retreatment needed in 10-20% coiled aneurysms

Statistic 81

Quality of life reduced in 60% long-term

Statistic 82

Pediatric rupture mortality 25-35%

Statistic 83

Case-fatality 51% for SAH globally

Statistic 84

10-year survival 60% post-coiling

Statistic 85

Fatigue persistent in 70% at 1 year

Statistic 86

Aneurysm growth rate 2-3mm/year in 10%

Statistic 87

UIATS recommends treatment for large symptomatic

Statistic 88

Smokers have a 3.5 times higher risk of aneurysm formation

Statistic 89

Hypertension increases aneurysm risk by 2-5 times

Statistic 90

Family history increases risk up to 6-fold

Statistic 91

Connective tissue disorders like Ehlers-Danlos raise risk significantly

Statistic 92

Polycystic kidney disease associated with 10-20% aneurysm prevalence

Statistic 93

Smoking cessation reduces rupture risk by 30% within 5 years

Statistic 94

Alcohol consumption >300g/week doubles risk

Statistic 95

Cocaine use increases rupture risk 6-fold

Statistic 96

Oral contraceptives may increase risk in smokers

Statistic 97

Bicuspid aortic valve associated with aneurysms

Statistic 98

Head trauma history elevates risk

Statistic 99

Atherosclerosis contributes to aneurysm growth

Statistic 100

Hypercholesterolemia as a risk factor OR 1.4

Statistic 101

Diabetes mellitus protective effect OR 0.5

Statistic 102

Pregnancy increases rupture risk 3-fold

Statistic 103

Loeys-Dietz syndrome high aneurysm risk

Statistic 104

Amphetamine use linked to dissection and aneurysms

Statistic 105

Obesity BMI>30 increases risk by 1.3x

Statistic 106

First-degree relatives screening recommended

Statistic 107

Estrogen deficiency post-menopause risk

Statistic 108

Untreated syphilis historical risk factor

Statistic 109

Marfan syndrome 10-25% aneurysm prevalence

Statistic 110

Chronic cocaine use OR 2.7 for SAH

Trusted by 500+ publications
Harvard Business ReviewThe GuardianFortune+497
While an estimated 6.5 million people in the US are unknowingly living with a brain aneurysm, this silent threat can strike with devastating suddenness.

Key Takeaways

  • About 6.5 million people in the US have an unruptured brain aneurysm
  • Brain aneurysms affect approximately 3-5% of the general population
  • Incidence of subarachnoid hemorrhage from aneurysm rupture is 6-10 per 100,000 person-years
  • Smokers have a 3.5 times higher risk of aneurysm formation
  • Hypertension increases aneurysm risk by 2-5 times
  • Family history increases risk up to 6-fold
  • Sudden severe headache in 97% of ruptured cases
  • Nausea and vomiting occur in 70-80% of rupture patients
  • Neck stiffness in 66% of subarachnoid hemorrhage cases
  • Coiling preferred endovascular treatment in 70% of cases
  • Clipping surgery used in complex aneurysms
  • Nimodipine reduces poor outcomes by 30% in SAH
  • 40-50% mortality rate for ruptured aneurysms
  • 66% of rupture survivors have permanent neurological deficits
  • Unruptured aneurysms rupture risk 1% per year average

Brain aneurysms affect millions and can rupture with severe consequences, but risk varies and treatment advances offer hope.

Clinical Presentation

  • Sudden severe headache in 97% of ruptured cases
  • Nausea and vomiting occur in 70-80% of rupture patients
  • Neck stiffness in 66% of subarachnoid hemorrhage cases
  • CT scan detects 95% of acute subarachnoid hemorrhages
  • MRI/MRA used for screening in high-risk patients
  • Digital subtraction angiography gold standard for aneurysm detection
  • Visual disturbances in 20% of ruptured cases
  • Loss of consciousness in 67% at rupture
  • Seizures occur in 10-25% post-rupture
  • Lumbar puncture confirms blood in CSF if CT negative
  • CTA has 92-97% sensitivity for aneurysms >3mm
  • Functional outcomes assessed by mRS scale
  • Photophobia in 30% of warning leaks
  • Sentinel headaches precede rupture in 40-50%
  • Focal deficits depend on location, e.g., III nerve palsy
  • Hunt-Hess scale predicts outcomes
  • Fisher scale for CT blood predicts vasospasm
  • Transcranial Doppler monitors vasospasm
  • Cranial nerve palsies in unruptured giant aneurysms
  • Mass effect symptoms in large aneurysms
  • WFNS scale for coma assessment
  • DSA detects 95% of aneurysms >2mm
  • Perimesencephalic SAH non-aneurysmal 10%

Clinical Presentation Interpretation

A sudden, skull-splitting headache is the brain's most urgent red flag, but behind that terrifying curtain lies a complex, meticulously charted landscape of symptoms, diagnostics, and scales where modern medicine fights to turn a potential catastrophe into a story of survival.

Epidemiology

  • About 6.5 million people in the US have an unruptured brain aneurysm
  • Brain aneurysms affect approximately 3-5% of the general population
  • Incidence of subarachnoid hemorrhage from aneurysm rupture is 6-10 per 100,000 person-years
  • Women are 1.6 times more likely to have brain aneurysms than men
  • Peak incidence of aneurysm rupture occurs between ages 40-60
  • African Americans have higher rupture rates
  • Annual incidence of aneurysmal SAH is 10 per 100,000
  • Prevalence higher in Finland at 85 per 100,000 for SAH
  • Lifetime risk of rupture for unruptured aneurysm 0.5-2%
  • Aneurysms found incidentally in 3.6% of autopsies
  • Hispanic population has lower prevalence than Caucasians
  • Age-adjusted incidence decreasing due to hypertension control
  • Global SAH incidence 7.9 per 100,000 person-years
  • Japanese population has higher incidence 22.7/100,000
  • Unruptured aneurysms detected in 1-2% of routine imaging
  • Multiple aneurysms in 20-30% of patients
  • Children <18 have aneurysms in 1-2% of pediatric strokes
  • Migraine sufferers have 1.5-2x higher prevalence
  • Incidence in elderly >65 rising with imaging
  • Saccular aneurysms 90% of cases
  • Mycotic aneurysms 1-2% from infection
  • Trauma-related pseudoaneurysms 5%
  • AVM-associated aneurysms 10-15%

Epidemiology Interpretation

While the odds are thankfully low for any one individual's unruptured brain aneurysm to burst, these statistics paint a stark portrait of a hidden, often silent threat that disproportionately shadows women, certain ethnic groups, and those with conditions like migraines, reminding us that vigilance in controlling risk factors like hypertension is our collective best defense.

Management and Treatment

  • Coiling preferred endovascular treatment in 70% of cases
  • Clipping surgery used in complex aneurysms
  • Nimodipine reduces poor outcomes by 30% in SAH
  • Endovascular repair has 5-10% lower complication rate than open surgery
  • Flow diversion stents used for large wide-neck aneurysms
  • Antifibrinolytics not recommended routinely
  • Surgical clipping recurrence rate 3-5%
  • Pipeline embolization device for fusiform aneurysms
  • Vasospasm treated with intra-arterial verapamil
  • Hydrocephalus in 20-30% of SAH cases requiring EVD
  • Stent-assisted coiling for wide-neck aneurysms
  • Barbiturate coma for refractory ICP
  • Decompressive craniectomy in 10-15% severe cases
  • Statins may reduce vasospasm incidence
  • Clazosentan failed phase III for vasospasm
  • Triple-H therapy for vasospasm (outdated)
  • Milrinone for refractory vasospasm
  • EVD infection rate 5-10%
  • Hypothermia trials failed for neuroprotection
  • Endovascular success 90-95% in selected cases

Management and Treatment Interpretation

While surgeons keep their shears sharp for complex cases, endovascular tools have become the first line of defense, deftly navigating arteries to coil, stent, and divert flow, turning what was once a perilous landscape of vasospasm, hydrocephalus, and high recurrence rates into a domain where nimodipine and modern techniques have steadily improved the odds of a better outcome.

Outcomes and Prognosis

  • 40-50% mortality rate for ruptured aneurysms
  • 66% of rupture survivors have permanent neurological deficits
  • Unruptured aneurysms rupture risk 1% per year average
  • Size >7mm increases rupture risk to 4% per year
  • Posterior circulation aneurysms rupture risk 2x higher
  • Rebleeding risk highest in first 24 hours at 4-6%
  • 30-day mortality for ruptured aneurysms 35-45%
  • Good outcome (mRS 0-2) in 40% of survivors
  • ISAT trial showed coiling better for anterior circulation
  • BRAT trial equivalence in long-term outcomes
  • Cognitive impairment in 50-75% of SAH survivors
  • 1-year mortality post-rupture 25% for good grade
  • Depression in 30-50% SAH survivors at 1 year
  • Retreatment needed in 10-20% coiled aneurysms
  • Quality of life reduced in 60% long-term
  • Pediatric rupture mortality 25-35%
  • Case-fatality 51% for SAH globally
  • 10-year survival 60% post-coiling
  • Fatigue persistent in 70% at 1 year
  • Aneurysm growth rate 2-3mm/year in 10%
  • UIATS recommends treatment for large symptomatic

Outcomes and Prognosis Interpretation

It presents a brutally ironic lottery where surviving the initial rupture is often just the opening bid in a lifelong auction for your health, leaving the majority of winners still paying a staggering neurological and psychological price.

Risk Factors

  • Smokers have a 3.5 times higher risk of aneurysm formation
  • Hypertension increases aneurysm risk by 2-5 times
  • Family history increases risk up to 6-fold
  • Connective tissue disorders like Ehlers-Danlos raise risk significantly
  • Polycystic kidney disease associated with 10-20% aneurysm prevalence
  • Smoking cessation reduces rupture risk by 30% within 5 years
  • Alcohol consumption >300g/week doubles risk
  • Cocaine use increases rupture risk 6-fold
  • Oral contraceptives may increase risk in smokers
  • Bicuspid aortic valve associated with aneurysms
  • Head trauma history elevates risk
  • Atherosclerosis contributes to aneurysm growth
  • Hypercholesterolemia as a risk factor OR 1.4
  • Diabetes mellitus protective effect OR 0.5
  • Pregnancy increases rupture risk 3-fold
  • Loeys-Dietz syndrome high aneurysm risk
  • Amphetamine use linked to dissection and aneurysms
  • Obesity BMI>30 increases risk by 1.3x
  • First-degree relatives screening recommended
  • Estrogen deficiency post-menopause risk
  • Untreated syphilis historical risk factor
  • Marfan syndrome 10-25% aneurysm prevalence
  • Chronic cocaine use OR 2.7 for SAH

Risk Factors Interpretation

Think of an aneurysm not as a random tragedy, but as a meticulous ledger where your genes write the principal, your habits calculate the interest, and every risky choice is a bold signature authorizing its growth.